Oluwafunmilayo Adenuga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oluwafunmilayo Adenuga has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Amber Otibhor Omoike
Department of Pharmacy, Irrua Specialist Teaching Hospital, Irrua, Edo State, Nigeria
1 shared publication - Chinaza Faith Ngwoke
School of Pharmacy and Health Science, United States International University Africa Nairobi, Kenya
1 shared publication - Enibokun Theresa Orobator
College of Medicine and Veterinary Medicine, Global Health and Infectious Diseases, University of Edinburgh, United Kingdom
1 shared publication Irene Adjoa Anderson
Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Ghana
1 shared publication- Josiah Stephen
Neonatal department, Royal Bolton Hospital, Minerva road Bolton, United Kingdom
1 shared publication - Olukunle O. Akanbi
Department of Psychology and Behavioral Sciences, National Louis University, FL, USA
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (1) , aubm001
Pharmacogenomics Applications in Clinical Practice: Revolutionizing Patient Care
Background: Personalised medicine through pharmacogenomics is revolutionalizing healthcare delivery by encouraging individualized therapy that takes into consideration an individual's genetic profile, environment and lifestyle. Pharmacogenomics is an aspect of pharmacy that studies the relationship between genetic profile and response to therapeutic agents. However, the application of the concepts of pharmacogenomics in healthcare helps in achieving more effective and safe responses from therapy. This study evaluates the application and benefits of pharmacogenomics in clinical practice based on evidence from current practices in various medical fields. Methods: In carrying out this review, PubMed database was the primary literature source and we analyzed and synthesized findings from the included literature thematically as it relates to pharmacogenomics applications, benefits and challenges as well as safety and ethical concerns. Results: Pharmacogenomics has been widely applied in various aspects of healthcare such as in dosing, choice of treatment, reducing and management of adverse reactions, individualization of therapy, optimizing efficacy of therapy. Despite its numerous applications, its adoption faces challenges such as limited clinical evidence, lack of specialized training among healthcare professionals, cost and complexity of genetic mapping as well as ethical concerns. Conclusion: With ongoing advances in genomic technologies, pharmacogenomics is becoming an integral aspect of individualization therapy in clinical practice and more widely applied in different healthcare sectors.
- 12 August 2025
- Published by Australasia Publishing Group in Australian Journal of Biomedical Research
- Vol. 1 (1) , aubm001
Open AccessPharmacogenomics Applications in Clinical Practice: Revolutionizing Patient Care
Background: Personalised medicine through pharmacogenomics is revolutionalizing healthcare delivery by encouraging individualized therapy that takes into consideration an individual's genetic profile, environment and lifestyle. Pharmacogenomics is an aspect of pharmacy that studies the relationship between genetic profile and response to therapeutic agents. However, the application of the concepts of pharmacogenomics in healthcare helps in achieving more effective and safe responses from therapy. This study evaluates the application and benefits of pharmacogenomics in clinical practice based on evidence from current practices in various medical fields. Methods: In carrying out this review, PubMed database was the primary literature source and we analyzed and synthesized findings from the included literature thematically as it relates to pharmacogenomics applications, benefits and challenges as well as safety and ethical concerns. Results: Pharmacogenomics has been widely applied in various aspects of healthcare such as in dosing, choice of treatment, reducing and management of adverse reactions, individualization of therapy, optimizing efficacy of therapy. Despite its numerous applications, its adoption faces challenges such as limited clinical evidence, lack of specialized training among healthcare professionals, cost and complexity of genetic mapping as well as ethical concerns. Conclusion: With ongoing advances in genomic technologies, pharmacogenomics is becoming an integral aspect of individualization therapy in clinical practice and more widely applied in different healthcare sectors.